Clinical Practice Guideline: Shared Decision Making, Diagnostic Evaluation, and Pharmacotherapy in Type 2 Diabetes.

导出 OA

翻译打印收藏纠错

作者： Christina,Brockamp ^[1] ; Rüdiger,Landgraf ; Ulrich Alfons,Müller ; Dirk,Müller-Wieland ; Frank,Petrak ; Til,Uebel ; the National Disease Management Guideline Group

作者单位： Agency for Quality in Medicine (AZQ), Berlin, Germany; German Diabetes Foundation (DDS), Düsseldorf, Germany; Medical Practice for Endocrinology and Diabetology, Jena, MVZ Dr. med. Kielstein Ambulante Medizinische Versorgung GmbH Erfurt, Germany; Department of Medicine I, University Hospital RWTH Aachen, Germany; Department of Psychosomatic Medicine and Psychotherapy, LWL-University Clinic Bochum, Ruhr-University Bochum, Germany; Center for Psychotherapy Wiesbaden MVZ GmbH; Primary physicians' offices Ittlingen and Neckargmünd, Germany, Specialists in diabetology. ^[1]

主题词老年人(Aged);人类(Humans);血糖(Blood Glucose);糖尿病, 2型(Diabetes Mellitus, Type 2);降血糖药(Hypoglycemic Agents)

DOI 10.3238/arztebl.m2023.0219

PMID 37874122

发布时间 2024-12-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交